BMS-708163 100mg 100mg | Purity Not Available
Adooq Bioscience
BMS-708163 is an oral gamma secretase inhibitor designed for selective inhibition of amyloid beta synthesis.
More Information Supplier PageBMS-708163 is an oral gamma secretase inhibitor designed for selective inhibition of amyloid beta synthesis.
More Information Supplier PageBMS-708163 is an oral gamma secretase inhibitor designed for selective inhibition of amyloid beta synthesis.
More Information Supplier PageBMS-707035 is an HIV-1 integrase (IN) inhibitor. HIV-1 integrase (IN) represents a therapeutically advantageous viral target to treat HIV/AIDS in the clinic.
More Information Supplier PageBMS-707035 is an HIV-1 integrase (IN) inhibitor. HIV-1 integrase (IN) represents a therapeutically advantageous viral target to treat HIV/AIDS in the clinic.
More Information Supplier PageBMS-707035 is an HIV-1 integrase (IN) inhibitor. HIV-1 integrase (IN) represents a therapeutically advantageous viral target to treat HIV/AIDS in the clinic.
More Information Supplier PageBMS-707035 is an HIV-1 integrase (IN) inhibitor. HIV-1 integrase (IN) represents a therapeutically advantageous viral target to treat HIV/AIDS in the clinic.
More Information Supplier PageBMS-707035 is an HIV-1 integrase (IN) inhibitor. HIV-1 integrase (IN) represents a therapeutically advantageous viral target to treat HIV/AIDS in the clinic.
More Information Supplier PageBMS-708163 is an oral gamma secretase inhibitor designed for selective inhibition of amyloid beta synthesis.
More Information Supplier PageBMS-708163 is an oral gamma secretase inhibitor designed for selective inhibition of amyloid beta synthesis.
More Information Supplier Page